Metraipolis › archive › dc_4f6850e4e57d

Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease — Europe PMC PMID:42226468

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42226468
DOI
10.1111/1346-8138.70314
License (as archived)
solo-consultazione
Archived
2026-10-07T21:22:35.515Z
SHA-256 of the archived text
fa8f9b4826e799144781c5cf95916c08a3b65f50e85bd3202d96eed8cdef3b05
Stable URL of this page
https://metraipolis.com/documento/dc_4f6850e4e57d

How to cite

Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease — Europe PMC PMID:42226468 — Europe PMC (en), https://europepmc.org/article/MED/42226468 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4f6850e4e57d (Metraipolis archive dc_4f6850e4e57d, sha256 fa8f9b4826e799144781c5cf95916c08a3b65f50e85bd3202d96eed8cdef3b05)
BibTeX
@misc{dc4f6850e4e57d,
  title = {Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease — Europe PMC PMID:42226468},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42226468},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4f6850e4e57d; sha256 fa8f9b4826e799144781c5cf95916c08a3b65f50e85bd3202d96eed8cdef3b05},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42226468. Agents can read the archived copy with the MCP tool read_document.